Sexual Health Assessment
We rely on polymerase chain reaction testing (PCR) for the most rapid, specific and sensitive testing available for HIV and HSV diagnosis. Our focus on clinically relevant targets means you get exactly the data you need to aid in diagnosis. Our extensive menu of women’s health test offerings makes adherence to national testing guidelines easy.
| Chlamydia |
CDC:
- Routine screening of all sexually active women aged = 25 years
- Routine screening should occur whether or not patient is pregnant
|
- 68363 CT & GC, TMA Amplified
- 68360 CT, TMA Amplified
|
| Gonorrhea |
CDC:
- Screening recommended for all young, sexually active women, including those who are pregnant
- Those with individual or population risk factors should also be screened
|
- 68363 CT & GC, TMA Amplified
- 68362 GC, TMA Amplified
|
| Cervical Cancer |
ACOG:
- First cervical cancer screening at age 21
- Screening every two years for women <30
- Screening every three years for women >30
|
- 70072 ThinPrep Pap
- 70066 ThinPrep Pap with HPV*
- 70062 SurePath Pap
- 70091 SurePath Pap with HPV*
*ThinPrep and SurePath testing for HPV >/+ 30 yr, HPV if ASCUS, and HPV if abnormal also available. |
| HIV |
U.S. Preventive Services Task Force:
- Routine screening for all adolescents and adults at increased risk for HIV infection
- All pregnant women should be screened for HIV
|
- 42040 HIV-1 RNA PCR, Ultra Sensitive 3
- 42000 HIV 1 and 2 Antibodies; Reflex by Western Blot
- 42156 HIV-1 Antibody, Rapid; Reflex by Western Blot
- 97250 HIV, Western Blot
|
| HSV |
U.S. Preventive Services Task Force:
- Patients who are clinically symptomatic
|
- 58490 HSV by Real-Time Polymerase Chain Reaction (PCR)
- 58481 HSV 1 & 2 Antibodies,
IgG & IgM
- 58462 HSV 1 Glycoprotein
G-Specific, IgG
- 58464 HSV 2 Glycoprotein
G-Specific, IgG
- 58471 HSV 1 & 2 Antibodies, IgM
|
